EBS News and Press, Emergent Biosolutions Inc. From 05/02/24

2024-05-02 12:58:43 ET DENVER, Colo., May 02, 2024 ( 247marketnews.com )- Brera Holdings (NASDAQ: BREA ) , Emergent BioSolutions Inc. (NYSE: EBS ), Aspen Aerogels, Inc. (NYSE: ASPN ), Allarity Therapeutics, Inc. (NASDAQ: ALLR ), and ...

Emergent BioSolutions Inc. (NYSE: EBS) is one today's most active stocks by volume. So far today, approximately 75.81M shares of Emergent BioSolutions Inc. have been exchanged, as compared to an average 30-day volume of 1.09M shares. Emergent BioSolutions Inc., a life sciences company, focuses...

2024-05-02 10:00:43 ET More on Health Care Select Sector SPDR XLV: Pivotal Week Of Earnings For Healthcare Stocks XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance 19 out...

A look at the top 10 most actives in the United States Allarity Therapeutics Inc. (ALLR) rose 97.8% to $2.71 on volume of 44,141,232 shares Faraday Future Intelligent Electric Inc. (FFIE) fell 1.1% to $0.0456 on volume of 28,670,184 shares Emergent Biosolutions Inc. (EBS) rose 67.7% to $3...

2024-05-02 07:10:00 ET Summary Q1 earnings growth expectations have sharply declined more than usual as we enter earnings season. Over the past three months, Q1 growth projections have been adjusted downward by 21.5 percentage points, settling at a current year-over-year decline o...

2024-05-02 05:22:38 ET Emergent BioSolutions' ( NYSE: EBS ) shares climbed 60% in premarket trade on Thursday, after the company surpassed Street estimates for first quarter earnings, and unveiled layoff plans.... Read the full article on Seeking Alpha For further de...

2024-05-01 23:45:15 ET Image source: The Motley Fool. Emergent BioSolutions (NYSE: EBS) Q1 2024 Earnings Call May 01, 2024 , 5:00 p.m. ET Operator Continue reading For further details see: Emergent BioSolutions (EBS) Q1 2024 Earnings Call Tran...

2024-05-01 21:38:11 ET Emergent BioSolutions Inc. (EBS) Q1 2024 Earnings Call Transcript May 01, 2024, 05:00 PM ET Company Participants Joe Papa - President and CEO Rich Lindahl - EVP and CFO Paul Williams - SVP, Products Business Presentation Opera...

2024-05-01 17:03:46 ET More on Emergent Biosolutions Emergent BioSolutions Inc. (EBS) Q4 2023 Earnings Call Transcript Emergent BioSolutions Inc. 2023 Q4 - Results - Earnings Call Presentation New CEO Appointment A Clear Positive For Emergent BioSolutions Eme...

First Quarter 2024 Total Revenues of $300.4 million, above the prior guidance range First Quarter 2024 Net Income of $9.0 million and Adjusted EBITDA of $66.9 million Updates FY 2024 guidance GAITHERSBURG, Md., May 01, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) ...